BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 32039832)

  • 1. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
    Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
    Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.
    Chen Y; Zhao B; Wang X
    BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patrolling monocytes inhibit osteosarcoma metastasis to the lung.
    Chen T; Zhao L
    Aging (Albany NY); 2020 Nov; 12(22):23004-23016. PubMed ID: 33203789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma.
    Deng C; Xu Y; Fu J; Zhu X; Chen H; Xu H; Wang G; Song Y; Song G; Lu J; Liu R; Tang Q; Huang W; Wang J
    Cancer Sci; 2020 Jun; 111(6):1899-1909. PubMed ID: 32232912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of LPAR5
    He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
    Front Immunol; 2022; 13():909932. PubMed ID: 36591220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
    Lu G; Chen L; Wu S; Feng Y; Lin T
    Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.
    Yuan J; Yuan Z; Ye A; Wu T; Jia J; Guo J; Zhang J; Li T; Cheng X
    Front Immunol; 2021; 12():758845. PubMed ID: 34691083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
    Koirala P; Roth ME; Gill J; Piperdi S; Chinai JM; Geller DS; Hoang BH; Park A; Fremed MA; Zang X; Gorlick R
    Sci Rep; 2016 Jul; 6():30093. PubMed ID: 27456063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
    Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
    Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.
    Song YJ; Xu Y; Deng C; Zhu X; Fu J; Chen H; Lu J; Xu H; Song G; Tang Q; Wang J
    Front Immunol; 2021; 12():623762. PubMed ID: 33959121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
    Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
    Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
    Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.